Shunsuke Terasaka

Use of convolutional neural network as the first step of fully automated tumor detection on 11C-methionine brain PET

Wataru Takeuchi, Kenji Hirata, Hiroyuki Kobayashi, 2016 .

Convolutional neural network can help differentiate FDG PET images of brain tumor between glioblastoma and primary central nervous system lymphoma

Kenji Hirata, Osamu Manabe, Tohru Shiga, 2016 .

IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy

Kiyohiro Houkin, Shigeru Yamaguchi, Shunsuke Terasaka, 2013, Brain Tumor Pathology.

18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas

Kenji Hirata, Keiichi Magota, Tohru Shiga, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.

Lei Xing, Ruijiang Li, Hiroki Shirato, 2016, Radiology.

Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging

Kenji Hirata, Osamu Manabe, Keiichi Magota, 2015, European Journal of Nuclear Medicine and Molecular Imaging.